About Celltrion
![](/front/assets/common/images/introduce/img_history_keyvisual_pc.png)
![](/front/assets/common/images/introduce/img_history_keyvisual_mo.png)
![2023](https://cellhomeblob.blob.core.windows.net/files/history/241509340219-3f8b1863-31e9-4ff7-ac8d-43d9884de3dd.png)
-
Dec. 2023
Celltrion Inc. & Celltrion Healthcare Co., Ltd. merger completed
-
Oct. 2023
Remsima SC (US product name:Zymfentra) received approval by US FDA as novel therapeutics
-
May. 2023
Yuflyma receives approval by US FDA
![2022](https://cellhomeblob.blob.core.windows.net/files/history/241509330250-97f7f168-270c-4276-b2cc-0624ee4e3c56.png)
-
Sep. 2022
Vegzelma receives approval by US FDA
-
Aug. 2022
Vegzelma receives approval by Europe EMA
![2021](https://cellhomeblob.blob.core.windows.net/files/history/241509330229-72fc646b-83aa-47e3-8a40-627999a065d4.png)
-
Nov. 2021
Regkirona receives approval by Europe EMA
-
Feb. 2021
Yuflyma receives approval by Europe EMA
![2020](https://cellhomeblob.blob.core.windows.net/files/history/241509330206-463c4105-2973-4a0e-930f-b5da36933376.png)
-
Aug. 2020
Acquired Primary Care product assets for Asia Pacific markets from Takeda Ltd.
-
Feb. 2020
Reached KRW 1 trillion in annual sales
![2019](https://cellhomeblob.blob.core.windows.net/files/history/241509320240-b9811986-5e55-43f9-be5a-9337a6e233e8.png)
-
Nov. 2019
Remsima SC receives approval by Europe EMA
-
May. 2019
Expansion of Plant 1 (additional 50,000L) completed
-
Apr. 2019
Linezolid receives approval by US FDA
![2018](https://cellhomeblob.blob.core.windows.net/files/history/241509320203-0b47d762-20e5-4732-a350-f614ee5db5e4.png)
-
Dec. 2018
Herzuma receives approval by US FDA
-
Nov. 2018
Temixys receives approval by US FDA
Truxima receives approval by US FDA
-
Feb. 2018
Herzuma receives approval by Europe EMA
![2017](https://cellhomeblob.blob.core.windows.net/files/history/241509310236-a0164de4-1ee7-4c1b-baba-b4e506e5c51d.png)
-
Feb. 2017
Truxima receives approval by Europe EMA
![2016](https://cellhomeblob.blob.core.windows.net/files/history/241509310219-bad13fba-92df-4ab2-bf82-77859e9558b4.png)
-
Apr. 2016
Remsima receives approval by US FDA
![2015](https://cellhomeblob.blob.core.windows.net/files/history/241509310202-3a861c33-0160-464f-8f83-4898f61ca68f.png)
-
Jun. 2015
Plant 1 & 2 receive approval by US FDA on all cGMP manufacturing facilities
![2013](https://cellhomeblob.blob.core.windows.net/files/history/241509300239-52fd6be8-3227-4658-ac35-5642a67ed26d.png)
-
Aug. 2013
Remsima receives approval by Europe EMA
![2012](https://cellhomeblob.blob.core.windows.net/files/history/241509300222-530a8429-ba91-4ec5-a04f-f16a472cf466.png)
-
Jul. 2012
Remsima receives approval by Korea MFDS
![2011](https://cellhomeblob.blob.core.windows.net/files/history/241509300205-a849cb2d-5f0c-47be-bdb2-09d47ff97869.png)
-
Oct. 2011
Plant 2 (90,000L) completed
![2008](https://cellhomeblob.blob.core.windows.net/files/history/241509290245-129dab79-5195-4e86-b9fa-0738e22121fa.png)
-
Aug. 2008
Initial Public Offering (IPO)
![2007](https://cellhomeblob.blob.core.windows.net/files/history/241509290226-49cdbea3-2995-4a81-92fa-4732d7ae8933.png)
-
Dec. 2007
Plant 1 receives cGMP facility approval by US FDA
![2005](https://cellhomeblob.blob.core.windows.net/files/history/241509290201-4192b94e-120a-4600-9602-adb59e58b53a.png)
-
Jul. 2005
Plant 1 (50,000L) completed
-
Jun. 2005
Supply agreement with Bristol-Myers Squibb
![2002](https://cellhomeblob.blob.core.windows.net/files/history/241509280232-4d942a1c-b13d-4ffe-b34c-8aaa9800f144.png)
-
Feb. 2002
Celltrion founded